Immunologic activation of human syncytiotrophoblast by Plasmodium falciparum
© Lucchi et al. 2008
Received: 15 August 2007
Accepted: 29 February 2008
Published: 29 February 2008
Skip to main content
© Lucchi et al. 2008
Received: 15 August 2007
Accepted: 29 February 2008
Published: 29 February 2008
Malaria during pregnancy is characterized by the sequestration of malaria-infected red blood cells (iRBC) in the intervillous spaces of the placenta, often accompanied by the infiltration of maternal mononuclear cells, causing substantial maternal and foetal/infant morbidity. The iRBC bind to receptors expressed by the syncytiotrophoblast (ST). How ST responds to this interaction remains poorly understood. Because it is known that ST is immunoactive and can respond to infectious agents, the consequences of this ST-iRBC interaction should be investigated.
An in vitro system was used to assess the biochemical and immunological changes induced in ST by ST-adherent iRBCs. Changes in ST mitogen-activated protein kinase (MAPK) activation were assessed by immunoblotting and mRNA expression levels of selected cytokine and chemokines in primary ST bound by iRBC were determined using real-time, reverse transcription PCR. In addition, secreted cytokine and chemokine proteins were assayed by standard ELISA, and chemotaxis of PBMC was assessed using a two-chamber assay system.
Following iRBC/ST interaction, ST C-Jun N-terminal kinase 1 (JNK1) was activated and modest increases in the mRNA expression of TGF-β and IL-8/CXCL8 were observed. In addition, this interaction increased secretion of MIF and MIP-1α/CCL3 by ST and induced migration of PBMC towards iRBC-stimulated ST.
Results from this study provide the first evidence that ST participates in shaping the local immunological milieu and in the recruitment of maternal immune cells to the maternal blood space during placental malaria infection.
It is estimated that annually approximately 2.2 billion people are exposed to the risk for Plasmodium falciparum malaria infection and between 300–600 million clinical attacks are attributable to this parasite . Ninety percent of deaths occur in sub-Saharan Africa, the majority involving children less than five years of age. In addition to children, pregnant women (particularly those in their first pregnancy) are at highest risk of severe disease . A hallmark of malaria during pregnancy is the sequestration of malaria-infected red blood cells (iRBCs) containing late developmental stages in the intervillous spaces (IVS) of the placenta [3–5]. This is usually accompanied by the infiltration of maternal leukocytes, especially monocytes, in the IVS [6, 7] and haemozoin deposition [4, 8], resulting in what is referred to as placental malaria (PM). PM poses substantial risk to the mother, the foetus, and the neonate in the form of maternal anaemia and poor foetal outcomes such as low birth weight (LBW) and prematurity ([9, 10]; reviewed in [11, 12]).
The sequestration of iRBCs in the placenta is thought to be mediated in large part by the cytoadherence of iRBCs to placental receptors expressed in the IVS and on the syncytiotrophoblast (ST; foetal epithelial cells that are in direct contact with maternal blood within the IVS). Currently, it is believed that the glycosaminoglycan chondroitin sulfate A (CSA) is the principal placental iRBC receptor [13–15]. Other minor receptors are proposed to exist [16–19], although the role of hyaluronic acid  has recently been questioned . Parasite-encoded surface ligands expressed on the membrane of iRBCs are thought to facilitate this adherence. To date, the only well-studied cytoadherence parasite protein is the P. falciparum erythrocyte membrane protein-1 (PfEMP1) encoded by the highly polymorphic members of the var gene family [21, 22]. The most well characterized PfEMP1 variant identified to mediate iRBC binding to the placenta is VAR2CSA [23–25]. Despite intense effort to elucidate the placental host/parasite interaction on the molecular level, the consequences of this placental iRBC sequestration on ST cell function have largely been ignored.
The immunological consequences of malaria in pregnancy have been widely investigated. A protective IgG antibody response that blocks the binding of iRBC to CSA in the placenta has been shown to develop in a sex- and gravidity-dependent manner [26, 27]. In addition, several studies have demonstrated the presence of both proinflammatory and anti-inflammatory immune factors in malaria-infected placentas [28–31]. For example, increased amounts of Th1 cytokines such as TNF-α [29, 31], IFN-γ [29, 30] and IL-1β  have been demonstrated in PM-positive placental blood. Production of IL-10 by intervillous blood mononuclear cells (IVBMC) was also shown to be increased in PM [28, 30] and was hypothesized to be important in the control of the negative effects of Th1 cytokines on pregnancy [28–31]. In addition, several proinflammatory chemokines have been observed in association with PM including interleukin-8 (CXCL8/IL-8) [31, 32] and beta chemokines such as macrophage inflammatory protein-1 alpha (MIP-1α/CCL3), macrophage chemoattractant protein-1 (MCP-1/CCL2), I-309/CCL1  and MIP-1β/CCL4. . Massively elevated levels of macrophage migration inhibitory factor (MIF) were observed in the placental plasma from women with PM , and immunohistochemical analysis suggests that ST contributes to this increase, particularly in cases of PM (36). However, in most cases, the cell types responsible for the production of these immune factors have not been definitively identified, although cells of both foetal and maternal origin have been implicated[31, 32, 35]. While proinflammatory responses are important in the clearance of iRBCs and protection against PM, they have also been shown to play a major role in malaria pathophysiology and contribute to morbidity . These proinflammatory immune responses have been associated with the ensuing monocytic infiltration [6, 32] which has been associated with poor foetal outcomes [6, 7, 9]
Foetally-derived tissues have been demonstrated to be active participants in maintaining the immunological milieu at the maternal-foetal interface during pregnancy . However, their role during PM remains largely unknown. Furthermore, the consequences of iRBC sequestration in the IVS on the function of the immunologically active ST are not known. This has partly been due to the lack of a good in vitro model system with which to investigate this. Previous studies utilizing such a system  showed that the ST is capable of responding to iRBC binding via pan-tyrosine phosphorylation of ST proteins . In the present study, the impact of iRBC interaction/binding on ST cells was further investigated. Activation of immunologic signaling in ST was observed upon stimulation with P. falciparum infected-RBC selected for binding to ST. This activation was found to be associated with changes in cytokine and chemokine expression and secretion. Furthermore, this iRBC/ST interaction stimulated the chemotactic migration of peripheral blood mononuclear cells (PBMC).
Trophoblast isolation and cell cultures were performed as previously described . Briefly, BeWo cells were grown in minimum essential medium and induced to form ST (BeWoST) by use of 40 uM forskolin. Primary placental cytotrophoblast cells (CT) were isolated from fresh human placentas obtained from women delivering at Athens Regional Medical Center, Athens, Georgia, USA. Placentas were obtained with written, informed consent under approval by the University of Georgia and Athens Regional Medical Center Institutional Review Boards. The immunopurified cells were used immediately or cryopreserved in liquid nitrogen until use.
Plasmodium falciparum was cultured and selected for binding to ST as described elsewhere . Briefly, the FCR3 (Malaria Research and Reference Reagent Resource Center (MR4)) laboratory strain was sequentially panned on ST to select for ST-binders (iRBCST). The CS2 isolate (MR4), known to bind to CSA, was also included. The parasites were synchronized by freezing and thawing or by sorbitol purification  and experiments performed using the FCR3 selected cultures consisting largely of mature trophozoite and schizont stages that bind to ST. The parasite cultures were routinely tested and found negative for mycoplasma contamination by PCR. All experiments used FCR3 except where noted.
BeWoST were incubated with iRBCST for given time points after which whole-cell lysate extracts were obtained as described . Unstimulated cells or cells incubated with uninfected RBC (uRBCs) were included in the assays as controls. Immunoblotting was carried out as described earlier  with a few changes. The membranes were probed with primary antibodies against phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2), C-Jun N-terminal kinase 1 (JNK1) and p38 (Cell Signaling Technology Inc., Beverly, MA) as recommended by the manufacturer. Final detection was performed with appropriate horseradish peroxidase-labelled (HRP) secondary antibodies (Sigma St. Louis, MO) in blocking buffer for one hour at room temperature. Phosphorylated proteins were visualized by enhanced chemiluminescence (SuperSignal, Pierce, Rockford, IL). Each membrane was stripped with freshly prepared stripping buffer (2% SDS; 62.5 mM Tris-HCl, pH 6.7; 100 mM 2-mercaptoethanol) and reprobed in a similar fashion with antibodies to the housekeeping gene, β-actin (Sigma, St. Louis, MO). The latter was used as a loading control and for densitometric analysis performed using QuantityOne software (Bio-Rad, Hercules, CA).
Oligonucleotide primers used in the amplification of the genes
18 S Forward
Primary ST were stimulated over a 24 hour time course with iRBCST, uRBCs or left unstimulated. Supernatants were collected from the stimulated cells and stored until use. As a control, wells containing uRBCs or iRBCST with no ST were included in the experiments and supernatants collected. A standard cytokine sandwich ELISA was performed according to the manufacturer's protocol (R&D Systems, Inc. Minneapolis, MN) for TNF-α, TGF-β, IL-10, MIF, MIP-1α/CCL3, MIP-1β/CCL4, and IL-8/CXCL8. ELISA results for TGF-β were inconsistent and difficult to interpret and thus were not included in the analysis.
Peripheral blood was obtained from healthy female American volunteers by a trained phlebotomist. An equal part of sterile phosphate buffered saline (PBS) was added to the blood and this was layered on fico-lite LymphoH (Atlanta Biological, Atlanta, GA) in a 50 ml centrifuge tube. To obtain PBMCs, the tube was centrifuged at 355 × g for 30 minutes at 25°C. The interface, containing the PBMCs, was collected and washed twice with sterile PBS. The cells were counted and used for the chemotaxis experiments. ST cells were grown in 24-well plates (BD Biosciences, Franklin Lakes, NJ) and stimulated with iRBCST or uRBCs for 12 hours or left unstimulated. PBMCs were used at 5 × 105 cells/ml. 3-μm pore size cell culture inserts (BD Biosciences, Franklin Lakes, NJ) were placed into each well and 350 μl of PBMC were added and allowed to migrate for 12 hours. The inserts were removed and placed in new wells. Using a cotton swab the inserts were carefully wiped to remove cells that had not migrated. Migrated cells, on the underside of the membranes, were stained with calcein-AM (Molecular Probes, Eugene, OR) for 30 minutes at 37°C and washed 3 times. The number of migrated cells was then determined by counting eight random fields under an inverted fluorescence microscope at 20× magnification.
A non-parametric Friedman's test was used to determine differences in the chemokine production and differences in the CT values for the real-time PCR. For chemotaxis experiments, the differences in number of migrated cells upon stimulation with the different stimuli were analysed using a student's t-test.
Results from this study demonstrate for the first time that the ST is capable of responding immunologically to interaction with P. falciparum -infected RBCs selected for binding to ST. This was evidenced by the induction of MAPK pathways, secretion of immune factors such as MIF and MIP-1α/CCL3, and induction of migration of PBMC towards iRBCST-stimulated ST.
The activation of MAPK pathways via phosphorylation is initiated by a large variety of external signals and leads to a wide range of cellular responses, including growth, differentiation, inflammation, apoptosis (reviewed in ), and secretion of cytokines (reviewed in ). This study demonstrates that the interaction of iRBCST with ST cells leads to the activation of the JNK1 pathway. In a previous study, the binding of iRBCST to ST cells was shown to result in the tyrosine phosphorylation of at least two ST proteins , altogether suggesting that a number of components of cellular activation pathways are activated in ST in the context of PM.
Indeed, the ST is known to be immunoactive, secreting cytokines and chemokines important for the maintenance of pregnancy  and in response to bacterial infections [41, 42] and lipopolysaccharide . The interaction with iRBCST led to the secretion of MIF and MIP-1α/CCL3 by ST. MIP-1α/CCL3 levels were shown to be increased in placental plasma of PM-positive women , although not so in another study . The current study suggests that the ST may contribute to elevated MIP-1α/CCL3 levels in the placenta during PM. However, dramatic variation in the magnitude of the secretion of MIP-1α/CCL3 (~300 pg/ml of MIP-1α/CCL3 from one placenta preparation to below detectable levels in others) was observed. This is not unprecedented as other studies using isolated trophoblast cells from term placentas have reported variability in receptor expression on the trophoblast cells  and cytokine/chemokine secretion  among the different placenta preparations utilized.
Previous studies demonstrated that PM resulted in increased levels of MIF in the intervillous blood  and that BeWo cells, a trophoblastic cell line, secreted substantial amounts of MIF upon iRBCST interaction . Together, these studies implicate the ST as an important source of MIF. This cytokine is known to play an important biologic role during pregnancy . Importantly, it is also known to be involved in macrophage activation  and retention, as it inhibits macrophage migration. Therefore, MIF may play a role in the retention of maternal immune cells that may be recruited to the IVS by other chemokines such as MIP-1α/CCL3 and RANTES/CCL5 (unpublished data), leading to the increased levels of monocytes in the IVS during PM. Previous studies have shown that PM is commonly associated with monocyte recruitment to the IVS [6, 7] which, in turn, is associated with high levels of intervillous chemokines . Results from this study suggest that the ST contributes to the migration of immune cells into the IVS. It remains to be determined, however, what cell types are specifically migrating toward iRBC-stimulated ST and whether this activity contributes to protective or pathogenic effects in vivo.
Both IL-8/CXCL8 [31, 32] and TNF-α have been associated with PM in previous studies. In this study, however, ST constitutively secreted IL-8/CXCL8 in a stimulation-independent manner and did not secrete any detectable TNF-α. This implies that the increased levels of IL-8/CXCL8 and TNF-α observed in PM-positive placentas are not derived from ST.
Variability in the secretion and gene expression of the investigated chemokines and cytokines between ST preparations from individual donors was observed. This reflects the inherent variability of human-based immunologic studies. In this context, it is important to keep in mind that differences in host genetic backgrounds contribute to the heterogeneities of malaria morbidity and disease manifestations [48–52]. Indeed, some cases of PM are accompanied by a massive infiltration of maternal mononuclear cells into the IVS but not others. It is currently unknown if these different disease manifestations are the result of variations in chemokine levels in the IVS which are driven by host genetic polymorphisms.
The experimental design utilized in the current study does not allow one to categorically claim that the effects observed were all directly due to the binding of iRBCST. Both late stage trophozoites and schizonts (early and mature) were used to stimulate the ST and this co-culture was incubated for up to 24 hours in some experiments. Especially at late time points, some of the schizonts would have ruptured, releasing both haemozoin and glycosylphosphatidylinositol (GPI) among other host- and parasite-derived materials. Thus, it is possible that these malarial products also stimulated the ST cells. However, this system is not physiologically irrelevant. On the contrary, this complex mixture of malarial products and iRBCs is precisely what the ST cells experience in vivo, and, in fact, ongoing unpublished work suggests that haemozoin is a potent stimulator of ST immunologic responses (N. Lucchi et al., unpublished data). Nonetheless, further experiments including controls such as unselected iRBC or var2csa -null P. falciparum would reveal the extent to which the hypothesized points of iRBCST/ST interaction (i.e., var2csa -encoded PfEMP1 and CSA) are required for ST activation. Furthermore, determining whether or not iRBCST binding affects non-immunologic ST functions such as nutrient and gaseous exchange could shed some light on the mechanisms leading to LBW associated with PM.
This study provides the first evidence that the interaction of malarial parasites with ST cells in the placenta induces immunologic changes in the ST cells as evidenced by the activation of the MAPK pathways, upregulated secretion of MIF and MIP-1α/CCL3, and stimulation of PBMC chemotaxis. Thus, ST cells play an active immunological role in response to malarial parasites in the placenta and are capable of influencing and/or contributing to the local maternal immune environment.
We thank all the placenta donors and nurses at Athens Regional Medical Center, Athens, Georgia without whose cooperation this study would not have been possible. The work was supported by a Faculty Grant from the University of Georgia Research Foundation and Grant # RO1AI050240 to JMM from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIAID or the National Institutes of Health.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.